Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fray F Marshall

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The American Journal of Surgical Pathology|January 28, 2003
Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarraysAndrew N Young, Paulo G de Oliveira Salles, So Dug Lim, et al.
Urology|May 16, 2006
Current trends in molecular classification of adult renal tumorsAndrew N Young, Jennifer Dale, Qiqin Yin-Goen, et al.
Cancer Detection and Prevention|July 18, 2006
The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsyMuta M Issa, Witold Zasada, Kevin Ward, et al.
Molecular Cancer|January 21, 2010
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cellsShumin Zhang, Haiyen E Zhau, Adeboye O Osunkoya, et al.
Cancer Research|September 5, 2006
Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinomaCarrie Q Sun, Rebecca Arnold, Carina Fernandez-Golarz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 16, 2003
Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomasCarlton D Donald, Carrie Q Sun, So Dug Lim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 19, 2010
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patientsSarfraz Ali, Qiqin Yin-Goen, Timothy V Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axisTakeo Nomura, Wen-Chin Huang, Haiyen E Zhau, et al.
Oncogene|January 8, 2005
Loss of HOXC6 expression induces apoptosis in prostate cancer cellsSumathi Ramachandran, Pengbo Liu, Andrew N Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2005
mtDNA mutations increase tumorigenicity in prostate cancerJohn A Petros, Amanda K Baumann, Eduardo Ruiz-Pesini, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|January 28, 2003
Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarraysAndrew N Young, Paulo G de Oliveira Salles, So Dug Lim, et al.
Urology|May 16, 2006
Current trends in molecular classification of adult renal tumorsAndrew N Young, Jennifer Dale, Qiqin Yin-Goen, et al.
Cancer Detection and Prevention|July 18, 2006
The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsyMuta M Issa, Witold Zasada, Kevin Ward, et al.
Molecular Cancer|January 21, 2010
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cellsShumin Zhang, Haiyen E Zhau, Adeboye O Osunkoya, et al.
Cancer Research|September 5, 2006
Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinomaCarrie Q Sun, Rebecca Arnold, Carina Fernandez-Golarz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 16, 2003
Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomasCarlton D Donald, Carrie Q Sun, So Dug Lim, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 19, 2010
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patientsSarfraz Ali, Qiqin Yin-Goen, Timothy V Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axisTakeo Nomura, Wen-Chin Huang, Haiyen E Zhau, et al.
Oncogene|January 8, 2005
Loss of HOXC6 expression induces apoptosis in prostate cancer cellsSumathi Ramachandran, Pengbo Liu, Andrew N Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2005
mtDNA mutations increase tumorigenicity in prostate cancerJohn A Petros, Amanda K Baumann, Eduardo Ruiz-Pesini, et al.
Pageof 8